22.97
+0.8(+3.61%)
Currency In USD
| Previous Close | 22.17 |
| Open | 22.22 |
| Day High | 23.14 |
| Day Low | 21.29 |
| 52-Week High | 92 |
| 52-Week Low | 9.62 |
| Volume | 245,929 |
| Average Volume | 284,120 |
| Market Cap | 150.68M |
| PE | -1.92 |
| EPS | -11.97 |
| Moving Average 50 Days | 22.08 |
| Moving Average 200 Days | 26.92 |
| Change | 0.8 |
If you invested $1000 in Instil Bio, Inc. (TIL) since IPO date, it would be worth $43.44 as of June 29, 2025 at a share price of $22.97. Whereas If you bought $1000 worth of Instil Bio, Inc. (TIL) shares 3 years ago, it would be worth $249.67 as of June 29, 2025 at a share price of $22.97.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program
GlobeNewswire Inc.
Jun 11, 2025 11:00 AM GMT
DALLAS, June 11, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced the addition of John Maraganore, Ph.D., to the Boar
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
GlobeNewswire Inc.
Jun 02, 2025 11:00 AM GMT
DALLAS, June 02, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel cancer therapies, today announced the appointment of Jamie Freedman, M.D., Ph.
Instil Bio to Participate in the 2025 Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 30, 2025 11:00 AM GMT
DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil"), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced that Bronson Crouch, Chief Executive Officer, will pr